IMULDOSA 130 mg/26mL
ustekinumab-srlf · INJECTION · Accord BioPharma Inc.
No Recall History
Plain English
IMULDOSA is a injection containing ustekinumab-srlf at 130 mg/26mL, taken intravenous. Manufactured by Accord BioPharma Inc..
Key Facts
- Brand Name
- IMULDOSA
- Generic Name
- ustekinumab-srlf
- NDC Code (Product)
69448-019- Manufacturer
- Accord BioPharma Inc.
- Strength
- 130 mg/26mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761364
- Marketing Start
- 10/18/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is IMULDOSA used for?
IMULDOSA contains ustekinumab-srlf. It is a injection taken intravenous. Consult your doctor for specific uses.
Is IMULDOSA a controlled substance?
IMULDOSA is not classified as a controlled substance by the DEA.
What is the generic name for IMULDOSA?
The generic name for IMULDOSA is ustekinumab-srlf. There are no other listed brand versions of ustekinumab-srlf.
What is the NDC code for IMULDOSA 130 mg/26mL?
The NDC (National Drug Code) for IMULDOSA 130 mg/26mL is 69448-019, listed by Accord BioPharma Inc..
Other IMULDOSA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)